Prezista Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Nucleosides And Darunavir/Dolutegravir In Africa
Condition:   Human Immunodeficiency Virus Interventions:   Drug: Darunavir;   Drug: Ritonavir;   Drug: Dolutegravir;   Drug: Zidovudine;   Drug: Tenofovir;   Drug: Lamivudine Sponsors:   Makerere University;   Infectious Diseases Institute, Uganda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2019 Category: Research Source Type: clinical trials